Table of Content

1 Study Coverage
1.1 Hepatitis A Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Hepatitis A Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hepatitis A Vaccine Regions by Sales
2.4.1 Global Top Hepatitis A Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Hepatitis A Vaccine Regions by Sales (2022-2027)
2.5 Global Top Hepatitis A Vaccine Regions by Revenue
2.5.1 Global Top Hepatitis A Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Hepatitis A Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Global Top Hepatitis A Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hepatitis A Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Sales in 2020
3.2 Global Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Global Top Hepatitis A Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hepatitis A Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis A Vaccine Revenue in 2020
3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hepatitis A Vaccine Sales by Type
4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Hepatitis A Vaccine Revenue by Type
4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Hepatitis A Vaccine Price by Type
4.3.1 Global Hepatitis A Vaccine Price by Type (2016-2021)
4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Hepatitis A Vaccine Sales by Application
5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Hepatitis A Vaccine Revenue by Application
5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Hepatitis A Vaccine Price by Application
5.3.1 Global Hepatitis A Vaccine Price by Application (2016-2021)
5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Hepatitis A Vaccine Market Size by Type
6.1.1 North America Hepatitis A Vaccine Sales by Type (2016-2027)
6.1.2 North America Hepatitis A Vaccine Revenue by Type (2016-2027)
6.2 North America Hepatitis A Vaccine Market Size by Application
6.2.1 North America Hepatitis A Vaccine Sales by Application (2016-2027)
6.2.2 North America Hepatitis A Vaccine Revenue by Application (2016-2027)
6.3 North America Hepatitis A Vaccine Market Size by Country
6.3.1 North America Hepatitis A Vaccine Sales by Country (2016-2027)
6.3.2 North America Hepatitis A Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis A Vaccine Market Size by Type
7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2027)
7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2027)
7.2 Europe Hepatitis A Vaccine Market Size by Application
7.2.1 Europe Hepatitis A Vaccine Sales by Application (2017-2027)
7.2.2 Europe Hepatitis A Vaccine Revenue by Application (2017-2027)
7.3 Europe Hepatitis A Vaccine Market Size by Country
7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2027)
7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application
8.2.1 Asia Pacific Hepatitis A Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Hepatitis A Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region
8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis A Vaccine Market Size by Type
9.1.1 Latin America Hepatitis A Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Hepatitis A Vaccine Revenue by Type (2019-2027)
9.2 Latin America Hepatitis A Vaccine Market Size by Application
9.2.1 Latin America Hepatitis A Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Hepatitis A Vaccine Revenue by Application (2019-2027)
9.3 Latin America Hepatitis A Vaccine Market Size by Country
9.3.1 Latin America Hepatitis A Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Hepatitis A Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type
6.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application
6.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country
6.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Hepatitis A Vaccine Product Description
11.1.5 GSK Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Hepatitis A Vaccine Product Description
11.2.5 Merck Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi Hepatitis A Vaccine Product Description
11.3.5 Sanofi Related Developments
11.4 Sinovac
11.4.1 Sinovac Corporation Information
11.4.2 Sinovac Overview
11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sinovac Hepatitis A Vaccine Product Description
11.4.5 Sinovac Related Developments
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Corporation Information
11.5.2 Zhejiang Pukang Overview
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Description
11.5.5 Zhejiang Pukang Related Developments
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Corporation Information
11.6.2 Changchun Institute of Biological Overview
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Description
11.6.5 Changchun Institute of Biological Related Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 KM Biologics Hepatitis A Vaccine Product Description
11.7.5 KM Biologics Related Developments
11.8 IMBCA
11.8.1 IMBCA Corporation Information
11.8.2 IMBCA Overview
11.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 IMBCA Hepatitis A Vaccine Product Description
11.8.5 IMBCA Related Developments
11.9 ChangSheng
11.9.1 ChangSheng Corporation Information
11.9.2 ChangSheng Overview
11.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 ChangSheng Hepatitis A Vaccine Product Description
11.9.5 ChangSheng Related Developments
11.10 Convac
11.10.1 Convac Corporation Information
11.10.2 Convac Overview
11.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Convac Hepatitis A Vaccine Product Description
11.10.5 Convac Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK Hepatitis A Vaccine Product Description
11.1.5 GSK Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Hepatitis A Vaccine Value Chain Analysis
12.2 Hepatitis A Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis A Vaccine Production Mode & Process
12.4 Hepatitis A Vaccine Sales and Marketing
12.4.1 Hepatitis A Vaccine Sales Channels
12.4.2 Hepatitis A Vaccine Distributors
12.5 Hepatitis A Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis A Vaccine Industry Trends
13.2 Hepatitis A Vaccine Market Drivers
13.3 Hepatitis A Vaccine Market Challenges
13.4 Hepatitis A Vaccine Market Restraints

14 Key Findings in The Global Hepatitis A Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Hepatitis A Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Hepatitis A Vaccine Sales by Region (2016-2021) & (K MT)
Table 7. Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global Hepatitis A Vaccine Sales by Region (2016-2021) & (K MT)
Table 9. Global Hepatitis A Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global Hepatitis A Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Hepatitis A Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global Hepatitis A Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Hepatitis A Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global Hepatitis A Vaccine Sales by Manufacturers (2016-2021) & (K MT)
Table 15. Global Hepatitis A Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global Hepatitis A Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Hepatitis A Vaccine Price by Manufacturers 2016-2021 (USD/MT)
Table 19. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2020)
Table 21. Hepatitis A Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis A Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Hepatitis A Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 26. Global Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 27. Global Hepatitis A Vaccine Sales Share by Type (2016-2021)
Table 28. Global Hepatitis A Vaccine Sales Share by Type (2022-2027)
Table 29. Global Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Hepatitis A Vaccine Revenue Share by Type (2016-2021)
Table 32. Global Hepatitis A Vaccine Revenue Share by Type (2022-2027)
Table 33. Hepatitis A Vaccine Price by Type (2016-2021) & (USD/MT)
Table 34. Global Hepatitis A Vaccine Price Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 36. Global Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 37. Global Hepatitis A Vaccine Sales Share by Application (2016-2021)
Table 38. Global Hepatitis A Vaccine Sales Share by Application (2022-2027)
Table 39. Global Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Hepatitis A Vaccine Revenue Share by Application (2016-2021)
Table 42. Global Hepatitis A Vaccine Revenue Share by Application (2022-2027)
Table 43. Hepatitis A Vaccine Price by Application (2016-2021) & (USD/MT)
Table 44. Global Hepatitis A Vaccine Price Forecast by Application (2022-2027) & (USD/MT)
Table 45. North America Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 46. North America Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 47. North America Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 50. North America Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 51. North America Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT)
Table 54. North America Hepatitis A Vaccine Sales by Country (2022-2027) & (K MT)
Table 55. North America Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Hepatitis A Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 58. Europe Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 59. Europe Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 62. Europe Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 63. Europe Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT)
Table 66. Europe Hepatitis A Vaccine Sales by Country (2022-2027) & (K MT)
Table 67. Europe Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Hepatitis A Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 70. Asia Pacific Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 71. Asia Pacific Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 74. Asia Pacific Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 75. Asia Pacific Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Hepatitis A Vaccine Sales by Region (2016-2021) & (K MT)
Table 78. Asia Pacific Hepatitis A Vaccine Sales by Region (2022-2027) & (K MT)
Table 79. Asia Pacific Hepatitis A Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Hepatitis A Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 82. Latin America Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 83. Latin America Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 86. Latin America Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 87. Latin America Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT)
Table 90. Latin America Hepatitis A Vaccine Sales by Country (2022-2027) & (K MT)
Table 91. Latin America Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Hepatitis A Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Hepatitis A Vaccine Sales by Type (2016-2021) & (K MT)
Table 94. Middle East and Africa Hepatitis A Vaccine Sales by Type (2022-2027) & (K MT)
Table 95. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Hepatitis A Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Hepatitis A Vaccine Sales by Application (2016-2021) & (K MT)
Table 98. Middle East and Africa Hepatitis A Vaccine Sales by Application (2022-2027) & (K MT)
Table 99. Middle East and Africa Hepatitis A Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Hepatitis A Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT)
Table 102. Middle East and Africa Hepatitis A Vaccine Sales by Country (2022-2027) & (K MT)
Table 103. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. GSK Corporation Information
Table 106. GSK Description and Major Businesses
Table 107. GSK Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 108. GSK Hepatitis A Vaccine Product
Table 109. GSK Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Merck Hepatitis A Vaccine Product
Table 114. Merck Recent Developments
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Sanofi Hepatitis A Vaccine Product
Table 119. Sanofi Recent Developments
Table 120. Sinovac Corporation Information
Table 121. Sinovac Description and Major Businesses
Table 122. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Sinovac Hepatitis A Vaccine Product
Table 124. Sinovac Recent Developments
Table 125. Zhejiang Pukang Corporation Information
Table 126. Zhejiang Pukang Description and Major Businesses
Table 127. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Zhejiang Pukang Hepatitis A Vaccine Product
Table 129. Zhejiang Pukang Recent Developments
Table 130. Changchun Institute of Biological Corporation Information
Table 131. Changchun Institute of Biological Description and Major Businesses
Table 132. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 134. Changchun Institute of Biological Recent Developments
Table 135. KM Biologics Corporation Information
Table 136. KM Biologics Description and Major Businesses
Table 137. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. KM Biologics Hepatitis A Vaccine Product
Table 139. KM Biologics Recent Developments
Table 140. IMBCA Corporation Information
Table 141. IMBCA Description and Major Businesses
Table 142. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. IMBCA Hepatitis A Vaccine Product
Table 144. IMBCA Recent Developments
Table 145. ChangSheng Corporation Information
Table 146. ChangSheng Description and Major Businesses
Table 147. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 148. ChangSheng Hepatitis A Vaccine Product
Table 149. ChangSheng Recent Developments
Table 150. Convac Corporation Information
Table 151. Convac Description and Major Businesses
Table 152. Convac Hepatitis A Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 153. Convac Hepatitis A Vaccine Product
Table 154. Convac Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Hepatitis A Vaccine Distributors List
Table 158. Hepatitis A Vaccine Customers List
Table 159. Hepatitis A Vaccine Market Trends
Table 160. Hepatitis A Vaccine Market Drivers
Table 161. Hepatitis A Vaccine Market Challenges
Table 162. Hepatitis A Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Market Share by Type in 2020 & 2027
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Hepatitis A Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Hepatitis A Vaccine Report Years Considered
Figure 10. Global Hepatitis A Vaccine Sales 2016-2027 (K MT)
Figure 11. Global Hepatitis A Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hepatitis A Vaccine Revenue 2016-2027 (US$ Million)
Figure 13. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Hepatitis A Vaccine Sales Market Share by Region (2022-2027)
Figure 16. North America Hepatitis A Vaccine Sales YoY (2016-2027) & (K MT)
Figure 17. North America Hepatitis A Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Hepatitis A Vaccine Sales YoY (2016-2027) & (K MT)
Figure 19. Europe Hepatitis A Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Hepatitis A Vaccine Sales YoY (2016-2027) & (K MT)
Figure 21. Asia-Pacific Hepatitis A Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Hepatitis A Vaccine Sales YoY (2016-2027) & (K MT)
Figure 23. Latin America Hepatitis A Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Hepatitis A Vaccine Sales YoY (2016-2027) & (K MT)
Figure 25. Middle East & Africa Hepatitis A Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Hepatitis A Vaccine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Hepatitis A Vaccine Revenue in 2020
Figure 28. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 30. Global Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 31. Global Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 32. Global Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 33. North America Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 34. North America Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 35. North America Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 36. North America Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 37. North America Hepatitis A Vaccine Sales Share by Country (2016-2027)
Figure 38. North America Hepatitis A Vaccine Revenue Share by Country (2016-2027)
Figure 39. U.S. Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 42. Europe Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 44. Europe Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 45. Europe Hepatitis A Vaccine Sales Share by Country (2016-2027)
Figure 46. Europe Hepatitis A Vaccine Revenue Share by Country (2016-2027)
Figure 47. Germany Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. France Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Hepatitis A Vaccine Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Hepatitis A Vaccine Revenue Share by Region (2016-2027)
Figure 58. China Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. India Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Philippines Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 69. Latin America Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 71. Latin America Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Hepatitis A Vaccine Sales Share by Country (2016-2027)
Figure 73. Latin America Hepatitis A Vaccine Revenue Share by Country (2016-2027)
Figure 74. Mexico Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Hepatitis A Vaccine Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Hepatitis A Vaccine Revenue Share by Country (2016-2027)
Figure 83. Turkey Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. U.A.E Hepatitis A Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. Hepatitis A Vaccine Value Chain
Figure 87. Hepatitis A Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed